Eva Maria Fenyö
41 – 50 of 73
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccines
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS
(
- Contribution to journal › Article
-
Mark
CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolates
(
- Contribution to journal › Article
-
Mark
Frequent intrapatient recombination between HIV-1 R5 and X4 envelopes: Implications for coreceptor switch.
(
- Contribution to journal › Article
- 2006
-
Mark
Isolation of human immunodeficiency virus-type 1 (HIV-1) clones with biological and molecular properties of the primary isolate.
(
- Contribution to journal › Article
-
Mark
Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): the kinetics of evolution to neutralization resistance are related to progression rate of disease.
(
- Contribution to journal › Article
-
Mark
Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): evolution of coreceptor use varies with pathogenic outcome.
(
- Contribution to journal › Article
-
Mark
Characterization of the human chemerin receptor - ChemR23/CMKLR1 - as co-receptor for human and simian immunodeficiency virus infection, and identification of virus-binding receptor domains.
(
- Contribution to journal › Article
- 2005
-
Mark
Quantitative evaluation of HIV and SIV co-receptor use with GHOST(3) cell assay.
(
- Contribution to journal › Article
-
Mark
Plaque-reduction assays for human and simian immunodeficiency virus neutralization.
(
- Contribution to journal › Article